-
Mashup Score: 39An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM - 3 year(s) ago
Original Article from The New England Journal of Medicine — An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Source: New England Journal of MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet
Data for which Dr. Zaks referred about antibody responses w/ 1 vs. 2 doses. Panel A shows binding antibodies after 1 dose. Sure, one needs a boost for robust neutralizing antibodies (panel C), but #bindingantibodiesmatter (day 1 = dose 1, day 29 = dose 2) https://t.co/ff52IKouKH https://t.co/xLFotIXxb7